Registered number: 14132341

Bloom Medical Ltd
Unaudited Financial Statements
for the period ended 31 May 2023

Statement of Financial Position

as at 31 May 2023

2023
 
££
Called up share capital not paid
  -  
Fixed assets
  -  
Current assets
18,908    
Prepayments and accrued income
-    
Creditors: amounts falling due within one year
( 5,387 )  
Net current assets (liabilities)
  13,521  
Total assets less current liabilities
  13,521  
Creditors: amounts falling due after more than one year
  -  
Provisions for liabilities
  -  
Accruals and deferred income
  -  
Net assets
  13,521  
   
Capital and reserves
  13,521  

xbrli:pure 14132341 2022-05-25 2023-05-31 14132341 2023-05-31 14132341 2022-05-25 14132341 uk-frs102:WithinOneYear 2023-05-31 14132341 uk-frs102:AfterOneYear 2023-05-31 14132341 uk-bus:AuditExempt-NoAccountantsReport 2022-05-25 2023-05-31 14132341 uk-bus:AbbreviatedAccounts 2022-05-25 2023-05-31 14132341 uk-bus:Director1 1 2022-05-25 2023-05-31 14132341 uk-bus:Director2 2 2022-05-25 2023-05-31 14132341 uk-bus:Director1 2022-05-25 2023-05-31 14132341 uk-bus:Director2 2022-05-25 2023-05-31 14132341 uk-bus:Director1 1 2022-05-25 14132341 uk-bus:Director2 2 2022-05-25 14132341 uk-bus:Director1 1 2023-05-31 14132341 uk-bus:Director2 2 2023-05-31 14132341 uk-bus:Micro-entities 2022-05-25 2023-05-31 14132341 uk-bus:PrivateLimitedCompanyLtd 2022-05-25 2023-05-31 iso4217:GBP 14132341 countries:EnglandWales 2022-05-25 2023-05-31 14132341 uk-bus:RegisteredOffice 2022-05-25 2023-05-31

Footnotes to the Statement of Financial Position

Ahmed Kamel Kvetoslava Kamel

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 2.

3. Directors’ benefits: advances, credit and guarantees

Ahmed Kamel

Included in creditors is an amount due to be paid by the company to one of its directors. The amount is an advance made to the company of £513 by Ahmed Kamel, a director of the company, on 25/07/2022.

During the accounting period the maximum amount repayable to Ahmed Kamel was £513

The following conditions are attached to amount payable to Ahmed Kamel:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid by the company.
Opening balance 25/05/2022 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 31/05/2023
£ £ £ £ £ £ £
0   ( 10 )
( 10 )
523
523  
0 0 0 513  
The Director Kvetoslava Kamel, has no amount owing to the company at the opening or closing date of the Statement of Financial Position.

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the period ending 31/05/2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 14132341

c) The company is a private company and is limited by shares

d) The companies registered office address is 3rd Floor 86-90 Paul Street, London, EC2A 4NE, England



Approved by the board of directors and signed on behalf of the board,

Bloom Medical Ltd
Director Ahmed Kamel
Date of approval: 13/02/2024
The company was trading for the entire period 2022-05-25 2023-05-31 2023-05-31 Specialist Medical Practice Activities 2024-02-13 2024-02-13